Effect of candesartan cilexetil on carotid intima-media thickness in hypertensive type 2 diabetic patients. MITEC study: design and baseline characteristics

Abstract

Media Intima Thickness Evaluation of Candesartan (MITEC), a multicentre, randomised, double-blind, parallel-group study assessed the effect of candesartan cilexetil (CC) versus amlodipine (AML) administered during three years, on carotid intima-media thickness (IMT) in hypertensive type 2 diabetic patients. The study design, the baseline characteristics, and the determinants of carotid IMT are presented.

After a placebo run-in period of four weeks, patients were randomised to CC (n=100) or AML (n=109). The mean blood pressure values were 155.9±11.0 mmHg, 91.3± 8.0 mmHg and 64.6±11.8 mmHg for systolic, diastolic and pulse pressure respectively, and the mean HbA₁C was 7.1±1.3%. The mean common carotid IMT was 0.74±0.16 mm. The univariate regression analyses showed a significant correlation between IMT and age (p<0.0001), gender (p=0.013) and creatinine clearance (p=0.03). Only age was significantly correlated with carotid IMT (p<0.0001) in the multivariate analysis.

In conclusion, the MITEC population has good metabolic control at baseline where carotid IMT is mainly related with age.

Keywords

candesartan cilexetil amlodipine carotid intima-media thickness diabetes hypertension.

Get full access to this article

View all access options for this article.

References

Barrett-Connor E. , Criqui MH , Klauber MR , Holdbrook M. Diabetes and hypertension in a community of older adults. Am J Epidemiol 1981;113: 276;84

Guidelines Committee , 2003 European Society of HypertensionEuropean Society of Cardiology guidelines for the management of arterial hypertension. J Hum Hypertens 2003;21:1011-53.

Prise en charge des patients atteints d'hypertension artérielle essentielle. Actualisation 2005. Haute Autorité Sanitaire.

Asmar RG , Topouchian JA , Benetos A. , Sayegh FA , Mourad JJ , Safar ME Non invasive evaluation of arterial abnormalities in hypertensive patients . J Hypertens 1997;15:99-107.

Franklin SS

Do diabetes and hypertension interact to accelerate vascular ageing?

J Hypertens 2002;20:1693-6.

Megnien JL , Simon A. , Valensi P. et al. Comparison of isobaric effects of hypertension and diabetes mellitus on geometric and elastic properties of human arteries. Arch Mal Coeur Vaiss 1991;84:1101-03.

Fruchart JC , Duriez P. Fundamental data on atherosclerosis. Ann Endocrinol 2001;62:93-100.

Tegos TJ , Kalodiki E. , Nicolaides AN , Sabetai MM , Stevens JM , Thomas DJ Brain CT infarction in patients with carotid atheroma.

Does it predict a future event?

Int Angiol 2001;20:110-17.

Mancia G. , Parati G. , Hennig M. et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;19:1981-9.

10.

Zanchetti A. , Hansson L. , Dahlof B. et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens 2001;19:1149-59.

11.

Poredos P. Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 2004;9:46-54.

12.

Cuspidi C. , Lonati L. , Macca G. et al. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography. J Hypertens 2001;19:375-80.

13.

O'Leary DH , Polak JF Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 2002;90:18L-21L.

14.

Chambless LE , Folsom AR , Clegg LX et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478-87.

15.

Pitt B. , Byington RP , Furberg CD et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102:1503-10.

16.

Terpstra WF , May JF , Smit AJ , Graeff PA , Meyboom-de Jong B. , Crijns HJ Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens 2004;22:1309-16.

17.

Zanchetti A. , Bond MG , Hennig M. et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomised, double-blind, long-term trial. Circulation 2002;106:2422-7.

18.

Nissen SE , Tuzcu EM , Libby P. et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomised controlled trial. JAMA 2004;292:2217-25.

19.

Coyle JD , Gardner SF , White CM The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother 2004;38:1731-8.

20.

Ariff B. , Stanton A. , Barratt D. et al. Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demo-graphics. J Renin Angiotensin Aldosterone Syst 2002;3:116-22.

21.

Ariff B. , Stanton A. , Barratt D. Candesartan cilexetil and atenolol have different effects on common carotid artery remodeling in hypertension. Hypertens 2003;21:S153.

22.

Pignoli P. , Tremoli E. , Poli A. , Oreste P. , Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;7:1399-406.

23.

Baguet JP , Mallion JM , Moreau-Gaudry A. , Noirclerc M. , Peoc'h M. , Siche JP Relationships between cardiovascular remodeling and the pulse pressure in never treated hypertension. J Hum Hypertens 2000;14:23-30.

24.

Tang R. , Hennig M. , Thomasson B. et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000; 18:197-201.

25.

Bots ML , Hoes AW , Koudstaal PJ , Hofman A. , Grobbee DE Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;6:1432-7.

26.

Chambless LE , Heiss G. , Folsom AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.

27.

Salonen JT , Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991a;11: 1245-9.

28.

Salonen R. , Salonen JT Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991b;229:225-31.

29.

Aminbakhsh A. , Mancini GB Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999;22:149-57.

30.

O'Leary DH , Polak JF , Kronmal RA , Manolio TA , Burke GL , Wolfson SK Jr. Carotid intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.

31.

Denarie N. , Gariepy J. , Chironi G. et al. Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes. Atherosclerosis 2000;148:297-302.

32.

Simon A. , Gariepy J. , Chironi G. , Megnien JL , Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159-69.

33.

Temelkova-Kurktschiev T. , Fischer S. , Koehler C. , Mennicken G. , Henkel E. , Hanefeld M. Intima-media thickness in healthy probands without risk factors for arteriosclerosis. Dtsch Med Wochenschr 2001;126:193-7.